Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.76 USD | -5.82% | -5.47% | +33.33% |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
May. 14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.33% | 31.69M | |
+42.26% | 54.04B | |
+43.57% | 41.96B | |
-1.16% | 41.92B | |
-7.59% | 28.35B | |
+11.92% | 26.35B | |
-22.22% | 19B | |
+8.04% | 13B | |
+29.01% | 12.28B | |
+25.47% | 12.19B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Viracta Therapeutics : SVB Leerink Initiates Viracta Therapeutics at Outperform With $18 Price Target